Variable | N | Mean | SD | Drug_effect | Treated_Mean | Estimated_Sample_Per_Arm |
|---|---|---|---|---|---|---|
FTLDCDR_SB | 293 | 1.633 | 2.696 | 30% reduction | 1.143 | 475.27 |
CBS_MOTOR_SCORE | 293 | 3.497 | 5.836 | 30% reduction | 2.448 | 485.873 |
CBS_TOTAL_SCORE | 293 | 7.692 | 13.01 | 30% reduction | 5.385 | 498.963 |
PSPRS_TOTAL | 293 | 3.529 | 8.105 | 30% reduction | 2.47 | 919.968 |
CBS_LCB_SCORE | 293 | 3.013 | 7.524 | 30% reduction | 2.109 | 1087.33 |
UPDRS_SCORE | 293 | 3.511 | 9.761 | 30% reduction | 2.458 | 1348.155 |
CBS_NONMOTOR_SCORE | 293 | 1.182 | 3.469 | 30% reduction | 0.827 | 1502.897 |
Variable | N | Mean | SD | Drug_effect | Treated_Mean | Estimated_Sample_Per_Arm |
|---|---|---|---|---|---|---|
FTLDCDR_SB | 149 | 1.981 | 2.515 | 30% reduction | 1.386 | 281.34 |
CBS_TOTAL_SCORE | 149 | 8.384 | 13.21 | 30% reduction | 5.869 | 433.034 |
CBS_MOTOR_SCORE | 149 | 3.944 | 6.374 | 30% reduction | 2.761 | 455.528 |
PSPRS_TOTAL | 149 | 4.749 | 8.82 | 30% reduction | 3.324 | 601.701 |
UPDRS_SCORE | 149 | 4.903 | 9.957 | 30% reduction | 3.432 | 719.355 |
CBS_NONMOTOR_SCORE | 149 | 1.438 | 3.602 | 30% reduction | 1.006 | 1095.023 |
CBS_LCB_SCORE | 149 | 3.002 | 7.633 | 30% reduction | 2.102 | 1127.466 |
Variable | N | Mean | SD | Drug_effect | Treated_Mean | Estimated_Sample_Per_Arm |
|---|---|---|---|---|---|---|
PSPRS_TOTAL | 30 | 8.511 | 6.93 | 30% reduction | 5.957 | 115.661 |
FTLDCDR_SB | 30 | 2.211 | 2.206 | 30% reduction | 1.548 | 173.663 |
CBS_TOTAL_SCORE | 30 | 11.418 | 13.13 | 30% reduction | 7.993 | 230.628 |
CBS_MOTOR_SCORE | 30 | 5.879 | 7.426 | 30% reduction | 4.115 | 278.307 |
UPDRS_SCORE | 30 | 9.031 | 11.512 | 30% reduction | 6.322 | 283.427 |
CBS_NONMOTOR_SCORE | 30 | 1.947 | 3.84 | 30% reduction | 1.363 | 678.425 |
CBS_LCB_SCORE | 30 | 3.592 | 8.326 | 30% reduction | 2.514 | 937.233 |
Variable | N | Mean | SD | Drug_effect | Treated_Mean | Estimated_Sample_Per_Arm |
|---|---|---|---|---|---|---|
CBS_MOTOR_SCORE | 29 | 6.821 | 7.783 | 30% reduction | 4.775 | 227.06 |
CBS_TOTAL_SCORE | 29 | 12.711 | 16.802 | 30% reduction | 8.898 | 304.776 |
FTLDCDR_SB | 29 | 2.12 | 2.803 | 30% reduction | 1.484 | 305.067 |
CBS_NONMOTOR_SCORE | 29 | 3.118 | 4.783 | 30% reduction | 2.182 | 410.532 |
UPDRS_SCORE | 29 | 7.9 | 13.79 | 30% reduction | 5.53 | 531.521 |
PSPRS_TOTAL | 29 | 7.184 | 13.287 | 30% reduction | 5.029 | 596.711 |
CBS_LCB_SCORE | 29 | 2.772 | 10.107 | 30% reduction | 1.94 | 2318.858 |
Variable | N | Mean | SD | Drug_effect | Treated_Mean | Estimated_Sample_Per_Arm |
|---|---|---|---|---|---|---|
FTLDCDR_SB | 67 | 1.886 | 2.745 | 30% reduction | 1.321 | 369.255 |
CBS_TOTAL_SCORE | 67 | 6.378 | 11.613 | 30% reduction | 4.465 | 578.202 |
CBS_LCB_SCORE | 67 | 3.083 | 6.89 | 30% reduction | 2.158 | 870.99 |
CBS_MOTOR_SCORE | 67 | 2.083 | 4.673 | 30% reduction | 1.458 | 878.207 |
CBS_NONMOTOR_SCORE | 67 | 1.212 | 3.085 | 30% reduction | 0.849 | 1129.469 |
PSPRS_TOTAL | 67 | 1.97 | 5.555 | 30% reduction | 1.379 | 1386.053 |
UPDRS_SCORE | 67 | 1.428 | 5.09 | 30% reduction | 1 | 2214.579 |
Variable | N | Mean | SD | Drug_effect | Treated_Mean | Estimated_Sample_Per_Arm |
|---|---|---|---|---|---|---|
FTLDCDR_SB | 28 | 1.597 | 1.948 | 30% reduction | 1.118 | 259.329 |
UPDRS_SCORE | 28 | 5.253 | 9.25 | 30% reduction | 3.677 | 540.825 |
CBS_MOTOR_SCORE | 28 | 3.016 | 5.365 | 30% reduction | 2.111 | 552.142 |
PSPRS_TOTAL | 28 | 3.989 | 8.948 | 30% reduction | 2.792 | 877.712 |
CBS_TOTAL_SCORE | 28 | 4.52 | 12.166 | 30% reduction | 3.164 | 1263.551 |
CBS_LCB_SCORE | 28 | 1.646 | 6.577 | 30% reduction | 1.152 | 2784.135 |
CBS_NONMOTOR_SCORE | 28 | -0.141 | 2.359 | 30% reduction | -0.099 | 48541.105 |
Variable | N | Mean | SD | Drug_effect | Treated_Mean | Estimated_Sample_Per_Arm |
|---|---|---|---|---|---|---|
FTLDCDR_SB | 150 | 0.071 | 0.375 | 30% reduction | 0.05 | 4894.004 |
CBS_LCB_SCORE | 150 | -0.319 | 2.217 | 30% reduction | -0.223 | 8448.715 |
CBS_TOTAL_SCORE | 150 | -0.379 | 3.754 | 30% reduction | -0.265 | 17148.707 |
PSPRS_TOTAL | 150 | -0.104 | 1.137 | 30% reduction | -0.073 | 20732.028 |
UPDRS_SCORE | 150 | 0.064 | 1.074 | 30% reduction | 0.045 | 48572.552 |
CBS_NONMOTOR_SCORE | 150 | -0.052 | 1.468 | 30% reduction | -0.037 | 137132.066 |
CBS_MOTOR_SCORE | 150 | -0.008 | 1.313 | 30% reduction | -0.005 | 5168753.05 |
Variable | N | Mean | SD | Drug_effect | Treated_Mean | Estimated_Sample_Per_Arm |
|---|---|---|---|---|---|---|
FTLDCDR_SB | 59 | 2.166 | 2.496 | 30% reduction | 1.516 | 231.565 |
CBS_MOTOR_SCORE | 59 | 6.342 | 7.553 | 30% reduction | 4.439 | 247.353 |
CBS_TOTAL_SCORE | 59 | 12.054 | 14.93 | 30% reduction | 8.437 | 267.604 |
PSPRS_TOTAL | 59 | 7.858 | 10.473 | 30% reduction | 5.501 | 309.82 |
UPDRS_SCORE | 59 | 8.475 | 12.586 | 30% reduction | 5.933 | 384.654 |
CBS_NONMOTOR_SCORE | 59 | 2.523 | 4.332 | 30% reduction | 1.766 | 514.415 |
CBS_LCB_SCORE | 59 | 3.189 | 9.173 | 30% reduction | 2.232 | 1443.368 |
Variable | N | Mean | SD | Drug_effect | Treated_Mean | Estimated_Sample_Per_Arm |
|---|---|---|---|---|---|---|
FTLDCDR_SB | 153 | 1.967 | 2.502 | 30% reduction | 1.377 | 281.992 |
CBS_TOTAL_SCORE | 153 | 8.078 | 13.293 | 30% reduction | 5.654 | 472.393 |
CBS_MOTOR_SCORE | 153 | 3.841 | 6.324 | 30% reduction | 2.689 | 472.726 |
PSPRS_TOTAL | 153 | 4.555 | 8.746 | 30% reduction | 3.189 | 642.991 |
UPDRS_SCORE | 153 | 4.787 | 9.847 | 30% reduction | 3.351 | 738.146 |
CBS_NONMOTOR_SCORE | 153 | 1.464 | 3.635 | 30% reduction | 1.025 | 1075.424 |
CBS_LCB_SCORE | 153 | 2.772 | 7.712 | 30% reduction | 1.94 | 1349.956 |